Free translation of all lectures from Greek to English and from English to Greek is provided.
Lectures
Free translation of all lectures from Greek to English and from English to Greek is provided.
DAILY SCHEDULE
11
January
1st day
13:00-14:00
Anna Foulidi
Head of Department of Food Policy and Legislation of the Front Office of Food Quality and Security of the Hellenic Ministry of Agricultural Development and Food
Lecture Title:
The legal frame of industrial and medical cannabis.
14:00-14:20
Ioannis Tsironis
Former Deputy Minister of Rural Development & Food
Lecture Title:
The future of medical cannabis in Greece.
14:20-15:00
Krista Pappa
Former Deputy Minister of Rural Development & Food
Lecture Title:
Industrial cannabis flowers: Possibilities and prospects for small and medium-sized producers.
15:00-16:00
George Nolas-Dermentzoglou
Professional Business Consultant & Marketing Director, 2MBA
Lecture Title:
Growth in foreign markets (Europe, the United States, Asia). Appropriate procedures for finding representatives.
16:00-17:00
George Nolas-Dermentzoglou
Professional Business Consultant & Marketing Director, 2MBA
Lecture Title:
Development of cannabis products at the pharmacy.
17:00-18:00
Steven P. Bennett
Molecular Biology, PhD, Prescott
Lecture Title:
Comprehensive cannabis processing for newly emerging markets.
Bio:
A leading expert in cannabinoid research, processing and product development, Dr. Bennett is a molecular biologist with a background in neurodegenerative disease, opiate receptors and melanoma. He holds two patents and four provisional patents and has published a series of peer-reviewed papers. Dr. Bennett has a PhD in Molecular Medicine from the University of South Florida College of Medicine and a BS in Biochemistry from Eckerd College.
Cannabinoid Scientist: My scientific career has focused on the molecular biology of disease, namely Alzheimer's disease (AD), melanoma, and opiate receptors. I consider myself a "bench to clinic" researcher as I am involved in numerous aspects of investigation. My work has led to 2 patents, 4 provisional patent submissions, and several publications over the past decade. I am currently a Visiting Scientist with CU-Anschutz Medical Campus in the department of Neurology with ongoing experiments in the field of Alzheimer's disease.
In July of 2015, I became the Scientific Director of Evolab, a Denver based cannabis extraction company focusing solely on the use of sub and supercritical CO2 extraction technology. We have since incorporated fractional distillation, preparative chromatography, analytical chromatography, and medical product development. Additionally, we have initiated an industry-academic hybrid research program with several state universities as well as Canadian universities. The research focuses on the role of cannabinoids and terpenes in various disease paradigms including neurodegeneration, cancer, and pain and spans from cell culture to small animals to clinical studies. We are always looking for the appropriate collaborators in both business and research, so please message me with any questions.
18:00-19:00
GIANNIS PRIONISTIS
Chemist, Hellamco S.A.
Lecture Title:
Scientific equipment for cannabis cultivation, processing and quality control.
19:00-20:00
PRESS CONFERENCE OF THE UNDER FORMATION ‘HELLENIC CANNABIS ASSOCIATION’
20:00-21:00
DIMITRIOS KATSINIS
Veterinarian, MBA, MA, International Relations, PhD Candidate on the Use of Cannabis to Animals
Lecture Title:
The use of cannabis to animals in the past, present and future.
21:00-22:00
KASHIF SHAN
Founder and CEO of Folium Biosciences
Lecture Title:
The Global Opportunity for Non-Psychoactive Cannabinoids.
Bio:
Folium Biosciences' founder and CEO, Kashif Shan, enjoyed a 2 decade long executive career in high technology where he oversaw finance, facilities, and human resources in the world’s technology capital: San Francisco. He was also involved in 3 public IPOs. In addition to his corporate ventures, he founded Equus Capital, a real estate investment company.
The Folium Biosciences story began in 2014, when Kash's own interests in the benefits of CBD developed. He sensed the industry’s explosive potential and knew that producing quality products meant helping the masses combat PTSD, opioid addiction, seizures and depression, just to name a few. As the largest vertically integrated producer, manufacturer, and distributor of hemp derived phytocannabinoids in The USA, Folium Biosciences has grown to become the global leader in non-psychoactive cannabinoids and employs over 200 people. Kash has a personal passion for helping veterans, and at least 10% of his workforce are veterans.
Folium Biosciences is a B2B, Bulk & Wholesale supplier of hemp derived CBD oil, CBD water soluble technology, 0.0% THC oil, CBD edibles, and CBD for pets. They proudly supply their unique 0.0% THC phytocannabinoid rich hemp oil to the cannabis industry, cosmetic, personal care, and animal health industry.
Folium Biosciences has a 70K square-food facility in Colorado’s La junta which supports its farming operations and a 100K square-food facility in Colorado Springs to manage their growing supplement division. They also have a 40K-square foot extraction facility. Mr. Shan just closed on a new 110K-square-foot facility, also in Colorado, to develop pharmaceutical operations. Construction on a facility in Canada marks the beginning of Folium Biosciences international expansion. This industry leader also ships their 0.0% THC white label, bulk and finished products To 26 countries around the world.
12
January
2nd day
12:00-13:00
DIMITRIS MPOURAS
CEO at Whitestone International
Lecture Title:
Development, design, permitting and construction of medical cannabis integrated projects.
13:00-14:00
ARGIRIS MOUTZOURIS
Cannabis Museum
Lecture Title:
The Greek cannabis bibliography.
14:00-15:00
BEN HORNER
Founder of Michigan Medical Marijuana Report
Lecture Title:
Value of social and medical reform using cannabis as a plant medicine. And the economic benefits of legalization in Urban cities in decline.
Bio:
Ben Horner, founder of Michigan Medical Marijuana Report (2011), has helped advance medical and recreational cannabis legalization in Michigan, opened the first medical cannabis dispensary in Flint, Michigan (2010) and has serviced over 15,000 medical cannabis patients. This year he opened a branch doctor's office for medical cannabis certification patients in Bay City, Michigan.
In October 2018 Ben hosted an event with Michigan State Representative Sheldon Neeley to promote expunge of criminal records of cannabis users.
15:00-16:00
KELLY KNUTSON
Founder and CEO of Isolate Extraction Systems Inc.
Lecture Title:
C02 extraction of Cannabis and Hemp.
Bio:
Mr. Knutson is a dedicated entrepreneur focused on equipment manufacturing and next generation technology development. He is a highly talented industrial designer/ fabricator with a broad understanding of technology enabling the ability to collaborate across many industries. As the founder and CEO of Isolate Extraction Systems Inc. (“IES”) he was able to create a leading product and brand within the supercritical extraction industry. Before IES Mr. Knutson, along with his brother and other founders, developed the production systems, operating procedures, and formulation of the award winning infused beverage known as Keef Cola.
16:00-17:00
MAGDA TSOLAKI
Neurologist, Psychiatrist, Theologist, MD, PhD, Professor at the Aristotelio Univerity of Thessaloniki, Director of the A’ Neurological Clinic, President of the Hellenic Federation of Alzheimer’s Disease
Lecture Title:
The role of cannabinoids in mental decline.
17:00-18:00
JACKIE POITRAS // SIMOS DALKYRIADIS // SOLON TAZOGLOU
Organization ‘Mothers in favour of cannabis’ (MAMA.KA.) // 1st Thessaloniki Cannabis Social Club
Lecture Title:
The usage for health: How do we find our ideal dosage and in which form?
18:00-19:00
GIORGIS IKONOMOPOULOS
Neurologist, Phychiatrist
Lecture Title:
We cultivate our health
19:00-20:00
CONSTANTINOS SIROS
President of ‘Patients in Favor of Medical Cannabis’
Lecture Title:
We cultivate our health.
20:00-21:00
RAJ GUPTA
Pharmaceutical Scientist, PhD, Responsible for R&D and Product Development at Folium Biosciences
Lecture Title:
Applying Clinical Knowledge to Design Effective Products.
Bio:
Dr. Raj Gupta is a pharmaceutical scientist, responsible for R&D and product development at Folium Biosciences. His vision is to perfect the science of product development to a point where consumer experience can be predicted based on an accurate translation of research into product design. To that effect, Dr. Gupta has contributed to patent-pending process technologies to remove psychoactive components while preserving the full spectrum profile of the phytocannabinoid-rich hemp extract. In order to deliver the advanced ingredients to the consumer, he has invented novel delivery technologies based on water-soluble nanoemulsion forms compatible with various routes of administration and suitable for micro-dosing and well as macro-dosing of cannabinoids. Dr. Gupta has also incorporated self-emulsifying delivery systems into the solid oral dosage forms to increase the consistency of experience through enhanced bioavailability compared with the traditionally natural and oily form of the canna binoids.
Before joining Folium Biosciences, he led the Technical Operations at Guthy-Renker (now Nestle), overseeing product development and manufacturing, resulting in commercialization of billion dollar brands, such as, Proactiv+. Earlier, he had managed quality and product development functions of orphan drugs like Kuvan% (sapropterin dihydrochloride), Firdapse (amifampridine), Aldurazyme (la ronidase), and Naglazyme% (galsulfase) at BioMarin Pharmaceutical as well as category-leading brands such as Clorox, Brita, Kingsford, Hidden Valley, and Fresh Step Scoop aT The Clorox Company.
Dr. Gupta has received a Ph.D. in Analytical Chemistry and an M.B.A., from University of Massachusetts, Amherst, and B.S./M.S. degrees from Indian lnstitute of Technology, Kharagpur. He has published multiple journal articles in the analytical chemistry and spectroscopy areas where his research has found numerous applications in industry.
13
January
3rd day
13:00-14:00
Fokion Bogris // Vaggelis Evaggelinos // Kostandinos "NOA" Vlahos // Maria Karagiannaki
Production Team of the Film 'Prostimo'
Lecture Title:
Presentation of the film 'Prostimo: The story of a small time cannabis dealer facing the Athens underworld', which is currently in pre-production.
14:00-16:00
PROKOPIS GEORGAKOPOULOS // KRISTA PAPPA // VASILIKI PRASSA //VAGGELIS MATRAKAS // DIMITRIS TSITOS
Cultivator, Owner of ‘Arcan’ // Kannabishop // Cultivator, Owner of ‘Philocanna’ // Kannevia // Farmer at ‘Mazi Farm’
Lecture Title:
Cannabis cultivation: The whole truth.
16:00-17:00
DIMITRIS GERONIKOS
Agronomist, MSc
Lecture Title:
Cannabis as a sustainability pillar in the years of climate change.
17:00-18:00
VASILIKI PRASSA
Cultivator, Owner of ‘Philocanna’
Lecture Title:
Cannabis, a plant.
18:00-19:00
SÉBASTIEN BÉGUERIE
Plant Sciences, MSc, Founder of ‘Alpha-CAT Lab’
Lecture Title:
Quality control and cannabinoid testing.
Bio:
Sébastien Béguerie, originated from Marseille, France, he did his MSc.degree in Plant Sciences, sponsored by Bedrocan BV to study at Wageningen University Research (WUR), in the Netherlands where he obtained his qualification. In 2009, he founded the first national medical Cannabis French patient association called " l' Union Francophone pour les Cannabinoids en Médecine” (UFCM). Together with his association, he has been organizing in Strasbourg (France) every year since 2012 an international medical Cannabis conference. In 2011 he founded his company Alpha-CAT Lab in Europe, manufacturing and providing cannabinoid test kit and CBD product, distributed worldwide from USA, Canada, Latin America, Jamaica, Australia, up to Japan. He became in 2015 a boar member of the International Association for Cannabinoid in Medicine (IACM). In this new emerging Cannabis industry, Sebastien is one of the European expert leader in medical cannabis science and quality control with now more than 10 years of experience in cannabis production, regulation, education and advocacy.
19:00-20:00
DIMITRIS TSITOS
Farmer at ‘Mazi Farm’
Lecture Title:
Regenerative agriculture being tested in Greek soil.
20:00-21:00
Robert Ivy // Jessica Ivy
Global Business Development of Folium Biosciences
Lecture Title:
Sourcing Hemp-Derived CBD: Not All Hemp is Created Equal.
Bio:
Robert Ivy and Jessica Ivy are a husband and wife team, working together in the Global Business Development division of Folium Biosciences, headquartered in Colorado. Prior to coming to Folium, they had been operating in the cannabis industry in California since 2014. Over the past five years, they have become advocates for the benefits of cannabis and hemp, more recently focusing on large-scale wholesale distribution of non-psychoactive cannabinoids. Robert comes from a background of Kinesiology and manual therapy. Jessica earned her Master's degree in Applied Statistics from the University of California, Davis and previously taught college courses in Math and Statistics.
20:00-21:00
Robert Ivy // Jessica Ivy
Global Business Development of Folium Biosciences
Lecture Title:
Sourcing Hemp-Derived CBD: Not All Hemp is Created Equal.
Bio:
Robert Ivy and Jessica Ivy are a husband and wife team, working together in the Global Business Development division of Folium Biosciences, headquartered in Colorado. Prior to coming to Folium, they had been operating in the cannabis industry in California since 2014. Over the past five years, they have become advocates for the benefits of cannabis and hemp, more recently focusing on large-scale wholesale distribution of non-psychoactive cannabinoids. Robert comes from a background of Kinesiology and manual therapy. Jessica earned her Master's degree in Applied Statistics from the University of California, Davis and previously taught college courses in Math and Statistics.